The results showed that high levels of HLA-DR/CD68 M1, CD204 M2, and CD68 macrophages were independently associated with improved survival rates in NSCLC patients, particularly with HLA-DR/CD68 M1 levels in lymph nodes being an independent positive prognostic indicator (38). Here, CD68 is linked to non-small cell lung carcinoma.